NETCast
NETCast is produced by the North American Neuroendocrine Tumor Society (NANETS) and focuses on neuroendocrine tumors. Each episode features leading neuroendocrine experts who discuss the latest research and debate the pros and cons of various treatment protocols. The show also covers topics such as establishing neuroendocrine centers of care. More information is available at nanets.net.
Episodes
Beyond the Tumor: Genetics, Cardiac Complications, and the Expanding NET Care Team
In this episode of NETCast, we explore two increasingly important, and often underrecognized, aspects of neuroendocrine tumor care: hereditary risk assessment and long-term systemic complications, including carcinoid heart disease.Hosted by Dr. Daniel Halperin and featuring experts in genetic counseling and cardio-oncology, the discussion examines how multidisciplinary NET care teams are
Beyond the Clinic: What Patients and Caregivers Need Most in NET Care
In this episode of NETCast, we explore the patient and caregiver experience beyond the clinic walls and examine what truly patient-centered care looks like within the neuroendocrine tumor community. Hosted by Dr. Daniel Halperin and featuring leaders from the Neuroendocrine Tumor Research Foundation and Neuroendocrine Cancer Foundation, this conversation focuses on the emotional realities
Multidisciplinary Management of Advanced NETs: Optimizing Long-Term Tumor Control
Recorded live at the NANETS Columbus Regional Conference, this episode of NETCast explores the multidisciplinary strategies that drive long-term tumor control in patients with advanced neuroendocrine tumors (NETs).Hosted by Drs. Jordan Cloyd and Bhavana Konda, the discussion brings together experts in medical oncology, surgical oncology, and gastroenterology to examine how treatment decis
Beyond the Data: How Physicians Talk to Patients About Uncertainty
In this episode of NETCast, host Dr. Emil Lou is joined by a multidisciplinary panel of experts and a patient advocacy perspective to explore one of the most nuanced aspects of neuroendocrine tumor care: how physicians communicate uncertainty when the data are limited, evolving, or open to interpretation.Featuring perspectives from medical oncology, surgical oncology, nuclear medicine, an
How Multidisciplinary Tumor Board Functions as the Engine Behind Complex NET Decision-Making
In this live recording from the Nashville Regional, we will explore the real-world impact of multidisciplinary NET specialty centers, particularly for patients initially diagnosed or managed in community settings. What structurally changes when a patient transitions from community-based care to an academic institution? And further, what distinguishes a general academic center from a dedic
Feocromocitoma y Paraganglioma (Spanish podcast on Pheochromocytoma & Paraganglioma)
Este podcast médico presenta una discusión entre los Drs. Sarimar Agosto, Alejandro Román-González y Camilo Jiménez sobre el manejo del feocromocitoma y paraganglioma. Manejo multidisciplinario esencial (endocrinología, oncología, cirugía, genética, radiología nuclear). Referir pacientes a centros de excelencia. Cada caso requiere individualización del tratamiento según progresión, locali
Hybrid Neuroendocrine Cancers: Pathology, Grade Transformation, and Emerging Therapies
This NETCast episode features Dr. Uday Grewal hosting a discussion with Drs. Aman Chauhan, Renuka Iyer, and Shagufta Shaheen on the complexities of hybrid neuroendocrine cancers. The panel explores transformation cases, mixed histology, and emerging DLL3-targeted therapies with lung cancer and CAR-T expertise.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at
Hot Topics in NET Clinical Care
This NETCast episode from the 2025 NANETS Symposium features Dr. Theodora Dimitra hosting a discussion with Drs. Alexandria Phan, Po H. Ear, Dawn Quelle, and Andrew Bellizzi on a range of hot topics. The panel discusses challenging NET clinical scenarios including biomarkers, GLP-1 medications, and surgical decision-making.See Privacy Policy at https://art19.com/privacy and California Pri
AI in Healthcare: Transforming NET Care Through Personalized Medicine
This episode of NETCast features Dr. Thorvardur Halfdanarson (Mayo Clinic oncologist) and Burt Rosen (patient advocate) discussing artificial intelligence's role in transforming healthcare, particularly for NET patients. Both guests agree AI represents a truly transformative shift—not just another overhyped technology—with potential to revolutionize drug discovery, clinical trial design,
Presidential Perspectives: The Evolution and Future of NET Care
This episode of NETcast features a "presidential panel" of three distinguished NANETS leaders: Dr. Jennifer Chan (president 2025, Dana-Farber), Dr. Simran Singh (incoming president, Sunnybrook), and Dr. Thorvardur Halfdanarson (president emeritus, Mayo Clinic). The discussion covers transformative developments in NET management over the past decade, including radiopharmaceuticals, targete
NET Patient Advocacy: A Multi-Stakeholder Perspective
This episode of NETCast features a panel on NET patient advocacy. They explore why advocacy is critical for this rare cancer, discussing challenges patients face at diagnosis, the importance of education and resources, research funding obstacles, and political advocacy efforts. The panel emphasizes that patients should be active participants in advocacy—whether through contacting rep
Current State of NETs, Successes, and Future Directions in Latin America
This podcast episode discusses the current state of neuroendocrine tumors in Latin America, focusing on the challenges and advancements in diagnosis and treatment. Experts from various countries share insights on the importance of education, registration, and multidisciplinary approaches in managing these tumors. The role of international societies like NANETS in supporting research and e
The Intersection of Compassion and Burnout in NETs
In this conversation, Jason Starr and Jessica Thomas discuss the critical intersection of mental health and oncology. They explore personal experiences with mental health challenges, the prevalence of burnout among healthcare providers, and the importance of resilience and wellness strategies. The discussion also delves into compassion fatigue, the necessity of setting boundaries for self
Promising Advances in NEC Research and Treatment
In this podcast, Dr. Garima Gupta meets with Dr. Renuka Iyer and Dr. Aman Chauhan to discuss the latest advancements in the treatment of neuroendocrine carcinomas, focusing on the differences between pulmonary and extra pulmonary types, treatment strategies for extensive stage cases, and the challenges faced in treating platinum refractory patients. They highlight the importance of clinic
Understanding the COMPETE Study and Its Implications
In this episode of the NET Podcast, Dr. Arshad meets with Dr. Soares, Dr. Shaheen, and Dr. Sonbol at the Tucson Regional Conference to discuss the evolving landscape of neuroendocrine tumors, focusing on recent studies such as the COMPETE study and the implications for treatment sequencing and patient care. They explore the importance of individualized treatment plans, the role
Terapias para tumores neuroendocrinos en México
¡Bienvenidos a nuestro primer podcast en español! En este episodio, el Dr. Ismael Domínguez Rosado hablará con la Dra. Cecilia Carreras y la Dra. Mónica Isabel Meneses Medina para revisar la agenda de nuestra Conferencia Regional en la Ciudad de México. Luego, discutirán terapias locales y regionales para tumores endocrinos en México.See Privacy Policy at https://art19.com/priva
2024 Symposium Abstracts: The Promise of PRRT in Neuroendocrine Tumor Treatment - Recorded November 22nd, 2024
In this episode of NETCAST, neuroendocrine experts Dr. Mosalem and Dr. Wahl meet with Taymeyah Al-Toubah discuss the latest advancements in neuroendocrine tumor treatments, focusing on peptide receptor radionuclide therapy (PRRT) with alpha and beta emitters. They delve into the safety and efficacy of new investigational agents, the challenges of hematological toxicity, and the
2024 Symposium Abstracts: New Research Using Biomarkers for Neuroendocrine Tumor Treatment - Recorded November 21st, 2024
In this podcast episode, neuroendocrine experts Dr. Liu and Dr. Gujarathi meet with Dr. Phan to discuss the latest advancements in neuroendocrine tumor research, focusing on innovative models for studying G1 and G2 neuroendocrine tumors, the implications of genetic mutations in pancreatic neuroendocrine tumors, and the future of drug screening and treatment protocols. The conver
2024 Symposium Abstracts: Innovative Therapies for Neuroendocrine Tumors - Recorded November 20th, 2024
In this episode of NETCAST, leading neuroendocrine experts Dr. Mohammed and Dr. Chauhan meet with Dr. Gangi to discuss their recent studies on innovative therapies for neuroendocrine tumors. Dr. Chauhan presents findings on Peltocetine, a new oral somatostatin receptor agonist, highlighting its efficacy in treating carcinoid syndrome. Dr. Mohammed shares insights on NP101, a combinat
2024 Symposium: Bridging the Gap with Patient Advocacy Groups - Recorded November 23rd, 2024
In this episode of NETCast, Dr. Jason Starr engages with patient advocacy leaders in the NET community to review highlights and insights from the 2024 NANETS Annual Symposium. Lisa Yen, Jessica Thomas, and Josh Mailman discuss the evolving role of patients in their care, the need for more therapies for neuroendocrine carcinoma, and the significance of building trust between patients and h
American Joint Committee on Cancer (AJCC) The Future of Neuroendocrine Tumor Management
In this episode, Dr. Aman Chauhan joins Dr. Renuka Iyer to discuss the critical updates in neuroendocrine tumors, focusing on the AJCC staging system and its implications for clinical practice. The conversation covers the evolution of staging systems, the role of biomarkers like chromogranin A, the importance of endoscopists in management, and the outcomes for appendiceal neuroendocrine t
DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell
DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell. Dr. Phan speaks with Dr. Jain about treatment options for neuroendocrine carcinoma.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
NET Regional Education Conference Jointly Provided by The University of Minnesota and The Mayo Clinic
NET Regional Education Conference Jointly Provided by The University of Minnesota and The Mayo Clinic. Dr. Lou and Dr. Halfdanarson spoke with Dr. Phan and Dr. Chandrasekharan about Systemic Therapy for NETs Beyond SSAs (Including Sequencing) and Well-differentiated G3 NETs.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy
Bridging the Gap: Patient Advocacy
Join us for Episode 24 of NETCast. Mayo Clinical Gastrointestinal Oncologist Dr. Jason Starr interviews Lisa Yen from LACNETS and Stephanie Alband from INCA and The PheoPara Alliance, patient advocacy groups that partner with NANETS. Join us as we discuss ways we are Bridging the Gap for patient advocacy.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at http
Discussion of the NETTER-2 Trial
Join us for Episode 23 of NETCast. Ohio State University Medical Oncology Specialist Dr. Vineeth Sukrithan interviews Dr. Simron Singh professor of medicine at the University of Toronto and co-founder of the Susan Leslie Clinic for Neuroendocrine Tumors. He is also a medical oncologist and affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute. Join us
Bone Marrow Toxicity Associated with PRRT
Join us for Episode 22 of NETCast. Mayo Clinical Gastrointestinal Oncologist Dr. Jason Starr interviews Hematologist & Oncologist Dr. Bassam Sonbol about bone marrow toxicity associated with PRRT.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Sequencing Of Therapies in Advanced NETs
Dr. Heloisa Soares is a medical oncologist and Associate Professor at the Huntsman Cancer Institute (HCI) at Universityof Utah. Neuroendocrine tumors and gastrointestinal (GI) cancers are the major focus of her research and clinical activities. Dr. Soares serves as the Medical Director for the Clinical Trials Office as well as the co-physician leader in
NET Regional Education Conference, at U Miami Health and jointly provided by Sylvester Comprehensive Cancer Center and NANETS
Join us for Episode 20 of NETCast. Today we are excited to bring a live taping from the NET Regional Education Conference, at U Miami Health and jointly provided by Sylvester Comprehensive Cancer Center and NANETS.Our guest moderator is Aman Chuahan, MD, is a medical oncologist at University of Miami, Leader of the Neuroendocrine Cancer Program and co-leader of the Diagnostic Dr
NANETS Communications Committee 2024 Plans and Projects
In this episode, Dr. Jason Starr. medical oncologist with Mayo Clinic, and Chair of NANETS Communications Committee, talks with NANETS Communications Director Maureen Werther about their goals and projects planned for 2024. Collaboration is the key focal point in '24. Tune in and learn about upcoming webinars, podcasts, programs and events that will be hosted jointly with our partner
NET Doctors Discuss Highlights from ASCO2024
Dr. Simron Singh is a medical oncologist, affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute, and an assistant professor at the University of Toronto. Dr. Singh is a longtime member of NANETS and the current Treasurer of its Board of Directors.Dr. Alexandria T. Phan is a Professor of Internal Medicine and Medical Oncology at Froedtert &
Highlights from NANETS’ 2023 Multidisciplinary NET Medical Symposium, Recorded in Detroit Nov. 2023
NET medical professionals gathered in Detroit in November 2023 to discuss highlights from NANETS' 2023 Multidisciplinary NET Medical Symposium held the previous month in Montreal. Internationally renowned cancer researcher and medical oncologist, Philip A. Philip, MD, PhD, Wayne State University, moderated a discussion with fellow NET medical professionals: Jonathan Strosberg, MD, who lea
NET Trials…and Tribulations, recorded live on Thursday, Oct. 5 at #NANETS2023
Here’s the latest episode of NETCast, recorded live at #NANETS 2023 Symposium in Montreal. Guest moderator, Dr. David Zhen, GI, Medical Oncology, Fred Hutchinson Cancer Center, is joined by Dr. Jennifer Eads, MD, Medical Oncology, Penn Medicine, Dr. Jennifer Chan, Medical Oncology, Dana-Farber Cancer Institute, and Josh Mailman,fierce patient advocate and President&nbs
Liver-Directed Therapies, recorded live on Wednesday, Oct. 4 at #NANETS2023
Dr. Gaby Gabriel, Associate Professor of Radiology and Surgery at U. of Kentucky, and member, NANETS Communications Committee, is our guest moderator for this commonly encountered management decision in NETs. He is joined by a distinguished panel of guest discussants: Dr. Callisia Clarke, Surgical Oncology, Medical College of Wisconsin; Dr. Nicholas Fidelman, Interventional
BioMarkers in NETs, recorded live on Friday, Oct. 6, at #NANETS2023
In this NETCast episode, guest Moderator, Virginia Corbett, MD, Oncology, Mt Sinai Hospital, is joined by NANETS President, Dr. Thorvardur Halfdanarson, Medical Oncology, Mayo Clinic, and Dr. Nitya Raj, Medical Oncology, Memorial Sloan Kettering,for a lively, open forum discussion on the always interesting and sometimes controversial topic of biomarkers
Radio Sensitizers in NETs, recorded live on Thursday, Oct. 5, at #NANETS2023
Tune in to NETCast to hear this recent discussion of an emerging topic in NET treatment, particularly PRRT.Participants include: Moderator Jaydira del Rivero, MD, Endocrine Oncology, National Cancer Institute, National Institutes of Health, and member of NANETS Board of Directors; Discussants – Aman Chauhan, MD, MedicalOncology, U. of Miami, Sylvester Ca
Highlights from NANETS 2023 Multidisciplinary NET Medical Symposium, Oct. 4-6, Montreal
In this episode of NETCast, recorded live on the final day of #NANETS2023, participants from the conference review the highlights of this year’s symposium, held in the beautiful city of Montreal, Quebec. Most importantly, find out who tried the poutine! The moderator of this episode is Jason Starr, DO, Medical Oncology, Mayo Clinic and Chair of NANETS Co
When Surgery is Indicated in NETs from G1- G3
In this episode of NETCast, " When Surgery is Indicated in NETs from G1- G3," we hear from a distinguished panel of leading NET medical professionals, including Dr. Julie Hallet, Odette Cancer Centre at the Sunnybrook Health Sciences Centre, Dr. Callisia Clarke, Medical College of Wisconsin, Dr. Alexandra Gangi, Cedars Sinai Samuel Oschin Comprehensive Cancer Institut
Negotiation 101: How To Grow the Pie & Get Your Fair Share with Dr. Anees Chagpar
A conversation with Anees Chagpar, MD, MSc, MPH, MA, MBA, FRCS(C) FACS, Professor, Dept of Surgery, Yale University School of Medicine about her upcoming Presentation at the NANETS 2nd Annual Women in NETS Luncheon, Fri, Oct. 6, 2023 in Montreal: "Negotiation 101: How to Grow the Pie and Get Your Fair Share."See Privacy Policy at https://art19.com/privacy and California Privacy Notice at
Hormonal Management of NETs: Syndromes and Symptom Control
In this episode of NETCast, which was taped live during NANETS' Cleveland NET Regional Educational Conference, leading NET medical experts held a discussion of Hormonal Management of NETs: Syndromes and Symptom Control, moderated by Amr Mohamed, MD, UH Seidman Cancer Center, University Hospital, and guests Lauren Fishbein, MD, PhD, University of Colorado, and Thorvardur Halfdanarson, MD,
NET Regional Educational Conference in Toronto
Tune in to hear our first taping of NETCast from Canada, recorded live during the NET Regional educational conference in Toronto. Our moderators are Dr. Julie Hallet and Dr. Simron Singh. Dr. Hallet is Associate Scientist, Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute, Assistant Professor, Dept. of Surgery, University of Toronto Surgical Oncol
Immunotherapy: Past, Present and Future Directions
Welcome to NETCast! Today's episode is "Immunotherapy: Past, Present and Future Directions." Our guest moderator, Renuka Iyer, MD, Roswell Park Comprehensive Cancer Institute, Buffalo, NY, is a medical oncologist and longtime NANETS member, currently serving on its Board of Directors. Dr. Iyer is the Co-Director of Roswell Park's Liver and Pancreas Tumor Center, Section Chief fo
Beyond Somatostatin Analogs
The topic of today's episode of NETCast is "Beyond Somatostatin Analogs." Our guest moderator is Dr. Junaid Arshad, Assistant Professor of Medicine and faculty member of GI Medical Oncology at the University of Arizona. Dr. Arshad received his medical degree from King Edward Medical University, Lahore, Pakistan and completed his Internal Medicine Residency at St. Mary's Hospital, Waterbur
NET Year in Review
In today's episode, we reprise the NET Year in Review lecture, originally presented by NANETS president, Dr. Pamela Kunz, at the 2022 NET Medical Symposium in Washington DC. Dr. Kunz is an Associate Professor of Internal Medicine (Medical Oncology); Director of the Center for Gastrointestinal Cancers at Smilow Cancer Hospital and Yale Cancer Center; Chief, GI Medical Oncology; Vice C
How to Boost Your NET Practice in a Non-Academic Setting
Listen in for this discussion recorded live from NANETS Annual conference with Dr. Alexandra Gangi, Cedars Sinai Medical Center as moderator, and Dr. Sandy Kotiah, Mercy Medical Center, and Dr. Mark Lewis, Intermountain Healthcare, as guests.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
High Grade NENs: Same Stripes, Different Disease.
Tune in for this live discussion recorded from NANETS annual conference and moderated by Dr. Jason Starr, Mayo Clinic, and featuring guests Dr. Jennifer Eads, Penn Medicine, and Dr. Aman Chauhan, University of Kentucky Markey Cancer Center.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Surgical DeBulking: Asymptomatic vs Symptomatic
Tune in for a lively debate on when, when not to, and if one should operate, with Diane Reidy-Lagunes, MD, Vice Chair of Oncology Operations, Regional Cancer Network; Past President, MSK Medical Staff; Creator and Host, Cancer Straight Talk Podcast, and past NANETS board member; and James Howe, MD, Professor of Surgery, Co-Director, Neuroendocrine Cancer Cli
NET Tumors 101: A Discussion about diagnosis, workup and treatment
Tune in to listen as leading NET medical experts from different areas of specialization discuss and debate key factors that are critical in diagnosing and treating NET patients.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Introducing NETCAST Podcast by NANETS
NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https
Recommended
True Crime Classics
The Healer Revolution
Becoming: HER with Nikki Spoelstra
Booked, Blonde & Busy w/ Olivia Ponton
McKinsey on Consumer and Retail
megahired.com
Hard Knocks Podcast
Effective Weight Loss for Moms | High protein, Strength Training, Lose Weight, Meal Planning, Fat Loss, Healthy Habits
The Human-Animal Connection - Pet Life Radio Original
Infinite Health with Dr. Arasi Maran
The Daily
World News Tonight with David Muir
